Vident Investment Advisory, LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,639,000
+69.0%
150,259
-6.7%
0.08%
+70.2%
Q2 2021$1,562,000
+6.3%
160,991
+17.7%
0.05%
-4.1%
Q1 2021$1,469,000
-26.4%
136,785
+0.7%
0.05%
-39.5%
Q4 2020$1,997,000
-18.4%
135,779
-21.1%
0.08%
-33.6%
Q3 2020$2,447,000
+70.8%
172,145
-2.8%
0.12%
+62.7%
Q2 2020$1,433,000177,1000.08%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders